Particle.news
Health ❯ Healthcare ❯ Clinical Trials
Patient Outcomes Phase 3 Trials Weight Loss Efficacy Lecanemab Phase 2 Trials Lecanemab Trials Weight Loss Outcomes STEP UP Trial Weight Loss Medications Orforglipron Lenacapavir Efficacy Progression-Free Survival OASIS 4 Trial Edison Histotripsy System Lecanemab Trial Results LUNA 3 Study DREAMM-8 Trial JUPITER-02 Trial Phase II Trials STEP Program Lecanemabe Acalabrutinib and Bendamustine-Rituximab Placebo-Controlled Trials Protein Therapy MONARCH 2 Trial Hormone Receptor-Positive Cancer CAPELLA Trial ACCESS Program Obesity Treatments Adverse Events Drug Comparisons Late-Stage Trials Orforglipron vs Semaglutide SELECT Trial Results POETYK PsA Trials Phase-3 Trials OLYMPIA Trials Weight Loss Trials Analytical Testing CheckMate 67T Non-Inferiority Trials SURMOUNT and SURPASS LITESPARK-022 Trial Long-term Data Semaglutide Trials Wegovy Oral Weight Management Minoxidil Absorption SUMMIT Trial STEP UP Trials Beamion LUNG-1 Trial ONWARDS Program ATTAIN-1 Trial Lenacapavir Randomized Trials Cagrilintide H3 K27M Mutations Pediatric Oncology Miplyffa MATTERHORN Trial Tirzepatide vs Dulaglutide Home Treatment Options Phase IIb/III Trials mNEXSPIKE Vaccine Lecanemab Efficacy Nature Medicine Publication AUGMENT-101 Trial Amycretin Trials MONARCH 3 Trial Asthma Exacerbations Simplify-1 Study FRESCO Trials Antibody Response DEVOTE Study Drug Side Effects TRANSCEND FL Study Weight Loss Drugs Obefazimod Rezafungin
Positive four-week data point to a potential monthly, non-hormonal alternative for hot flashes while larger trials and regulatory review are still required.
